Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis

被引:0
|
作者
Olivia Keiser
Ben Spycher
Andri Rauch
Alexandra Calmy
Matthias Cavassini
Tracy R. Glass
Dunja Nicca
Bruno Ledergerber
Matthias Egger
机构
[1] University of Bern,Institute of Social and Preventive Medicine (ISPM)
[2] Bern University Hospital and University of Bern,University Clinic for Infectious Diseases
[3] University Hospital Geneva,Division of Infectious Diseases
[4] University Hospital Lausanne,Division of Infectious Diseases
[5] University Hospital Basel,Basel Institute for Clinical Epidemiology and Biostatistics
[6] Cantonal Hospital St.Gallen,Division of Infectious Diseases
[7] University Hospital,Division of Infectious Diseases and Hospital Epidemiology
[8] University of Zürich,undefined
来源
AIDS and Behavior | 2012年 / 16卷
关键词
HIV infection; Antiretroviral therapy; Disease progression; Mortality; Social factors; Behavior; Latent class analysis;
D O I
暂无
中图分类号
学科分类号
摘要
An in-depth understanding of the different groups that make up the HIV-infected population should inform prevention and care. Using latent class analysis (LCA) we identified seven groups with similar socio-demographic and behavioral characteristics at enrolment in the Swiss HIV Cohort Study: older gay men, younger gay men, older heterosexual men, injection drug users, single migrants, migrant women in partnerships and heterosexual men and women. Outcomes of combination antiretroviral therapy (ART) were analyzed in 1,633 patients starting ART. Compared to older gay men, the probability of a virologic response to ART was reduced in single migrants, in older heterosexual men and in IDUs. Loss to follow-up was higher in single migrants and IDUs, and mortality was increased in older heterosexual men and IDUs. Socio-behavioral groups identified by LCA allow insights above what can be gleaned from traditional transmission groups, and may identify patients who could benefit from targeted interventions.
引用
收藏
页码:245 / 255
页数:10
相关论文
共 50 条
  • [31] Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
    Fellay, J
    Boubaker, K
    Ledergerber, B
    Bernasconi, E
    Furrer, H
    Battegay, M
    Hirschel, B
    Vernazza, P
    Francioli, P
    Greub, G
    Flepp, M
    Telenti, A
    LANCET, 2001, 358 (9290): : 1322 - 1327
  • [32] Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study
    Bayard, Cornelia
    Ledergerber, Bruno
    Flepp, Markus
    Lecompte, Thanh
    Moulin, Estelle
    Hoffmann, Matthias
    Weber, Rainer
    Staehelin, Cornelia
    Di Benedetto, Caroline
    Fux, Christoph A.
    Tarr, Philip E.
    Hasse, Barbara
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (04):
  • [33] Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis
    Patel, Kunjal
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 (04)
  • [34] Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study
    Dahab, Mison
    Charalambous, Salome
    Karstaedt, Alan S.
    Fielding, Katherine L.
    Hamilton, Robin
    La Grange, Lettie
    Churchyard, Gavin J.
    Grant, Alison D.
    BMC PUBLIC HEALTH, 2010, 10
  • [35] Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study
    Mison Dahab
    Salome Charalambous
    Alan S Karstaedt
    Katherine L Fielding
    Robin Hamilton
    Lettie La Grange
    Gavin J Churchyard
    Alison D Grant
    BMC Public Health, 10
  • [36] Small Dense Lipoproteins, Apolipoprotein B, and Risk of Coronary Events in HIV-Infected Patients on Antiretroviral Therapy: The Swiss HIV Cohort Study
    Bucher, Heiner C.
    Richter, Werner
    Glass, Tracy R.
    Magenta, Lorenzo
    Wang, Qing
    Cavassini, Matthias
    Vernazza, Pietro
    Hirschel, Bernard
    Weber, Rainer
    Furrer, Hansjakob
    Battegay, Manuel
    Bernasconi, Enos
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (02) : 135 - 142
  • [37] Cohort Profile: The Swiss HIV Cohort Study
    Schoeni-Affolter, Franziska
    Ledergerber, Bruno
    Rickenbach, Martin
    Rudin, Christoph
    Guenthard, Huldrych F.
    Telenti, Amalio
    Furrer, Hansjakob
    Yerly, Sabine
    Francioli, Patrick
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2010, 39 (05) : 1179 - 1189
  • [38] Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study
    Kusejko, Katharina
    Kouyos, Roger D.
    Bernasconi, Enos
    Boggian, Katia
    Braun, Dominique L.
    Calmy, Alexandra
    Cavassini, Matthias
    van Delden, Christian
    Furrer, Hansjakob
    Garzoni, Christian
    Hirsch, Hans H.
    Hirzel, Cedric
    Manuel, Oriol
    Schmid, Patrick
    Khanna, Nina
    Haidar, Fadi
    Bonani, Marco
    Golshayan, Dela
    Dickenmann, Michael
    Sidler, Daniel
    Schnyder, Aurelia
    Mueller, Nicolas J.
    Gunthard, Huldrych F.
    Schreiber, Peter W.
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [39] Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study
    Aebi-Popp, K.
    Kahlert, C.
    Crisinel, P.
    Decosterd, L.
    Saldanha, S. Alves
    Hosli, I.
    Tejada, B. Martinez
    Duppenthaler, A.
    Rauch, A.
    Marzolini, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 24 - 25
  • [40] Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival
    Staehelin, C
    Rickenbach, M
    Low, N
    Egger, M
    Ledergerber, B
    Hirschel, B
    D'Acremont, V
    Battegay, M
    Wagels, T
    Bernasconi, E
    Kopp, C
    Furrer, H
    AIDS, 2003, 17 (15) : 2237 - 2244